These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3345529)

  • 1. Reversal of transformed phenotypes by herbimycin A in src oncogene expressed rat fibroblasts.
    Murakami Y; Mizuno S; Hori M; Uehara Y
    Cancer Res; 1988 Mar; 48(6):1587-90. PubMed ID: 3345529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential growth sensitivity to 4-cis-hydroxy-L-proline of transformed rodent cell lines.
    Ciardiello F; Sanfilippo B; Yanagihara K; Kim N; Tortora G; Bassin RH; Kidwell WR; Salomon DS
    Cancer Res; 1988 May; 48(9):2483-91. PubMed ID: 2833347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herbimycin A inhibits the association of p60v-src with the cytoskeletal structure and with phosphatidylinositol 3' kinase.
    Hamaguchi M; Xiao H; Uehara Y; Ohnishi Y; Nagai Y
    Oncogene; 1993 Mar; 8(3):559-64. PubMed ID: 8382356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of pp60c-src protein kinase by herbimycin A in polyomavirus middle tumor antigen-transformed cells.
    Yang YW; Chang YH
    Anticancer Res; 1997; 17(5A):3273-9. PubMed ID: 9413159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Method of identifying inhibitors of oncogenic transformation: selective inhibition of cell growth in serum-free medium.
    Li PM; Fukazawa H; Yamamoto C; Mizuno S; Tanaka K; Hori M; Yaginuma S; Saito T; Uehara Y
    Oncogene; 1993 Jul; 8(7):1731-5. PubMed ID: 8510919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of reversion of Rous sarcoma virus transformation by herbimycin A: reduction of total phosphotyrosine levels due to reduced kinase activity and increased turnover of p60v-src1.
    Uehara Y; Murakami Y; Sugimoto Y; Mizuno S
    Cancer Res; 1989 Feb; 49(4):780-5. PubMed ID: 2463877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of herbimycin A on growth and pp60c-src activity in human colon tumor cell lines.
    Garcia R; Parikh NU; Saya H; Gallick GE
    Oncogene; 1991 Nov; 6(11):1983-9. PubMed ID: 1719464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction by herbimycin A of contact inhibition in v-src-expressed cells.
    Suzukake-Tsuchiya K; Moriya Y; Hori M; Uehara Y; Takeuchi T
    J Antibiot (Tokyo); 1989 Dec; 42(12):1831-7. PubMed ID: 2559910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reexpression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis.
    Lin X; Gelman IH
    Cancer Res; 1997 Jun; 57(11):2304-12. PubMed ID: 9187136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial characterization of the mitogenic action of pp60v-src, the oncogenic protein product of the src gene of avian sarcoma virus.
    Durkin JP; Whitfield JF
    J Cell Physiol; 1984 Aug; 120(2):135-45. PubMed ID: 6086674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myogenin expression is necessary for commitment to differentiation and is closely related to src tyrosine kinase activity in quail myoblasts transformed with Rous sarcoma virus.
    Hirayama E; Isobe A; Okamoto H; Nishioka M; Kim J
    Eur J Cell Biol; 1997 Feb; 72(2):133-41. PubMed ID: 9157009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clustered cysteine residues in the kinase domain of v-Src: critical role for protein stability, cell transformation and sensitivity to herbimycin A.
    Senga T; Miyazaki K; Machida K; Iwata H; Matsuda S; Nakashima I; Hamaguchi M
    Oncogene; 2000 Jan; 19(2):273-9. PubMed ID: 10645006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of agents which convert 'transformed morphology' of Rous sarcoma virus-infected rat kidney cells to 'normal morphology': identification of an active agent as herbimycin and its inhibition of intracellular src kinase.
    Uehara Y; Hori M; Takeuchi T; Umezawa H
    Jpn J Cancer Res; 1985 Aug; 76(8):672-5. PubMed ID: 3930444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of orthovanadate on commitment of avian myoblasts transformed with Rous sarcoma virus to myogenic differentiation.
    Hase H; Isobe A; Kim J
    Eur J Cell Biol; 1995 Nov; 68(3):313-22. PubMed ID: 8603684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease in epidermal growth factor receptor levels and production of material enhancing epidermal growth factor binding accompany the temperature-dependent changes from normal to transformed phenotype.
    Guinivan P; Ladda RL
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3377-81. PubMed ID: 315064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hexose sugar transport activity in a mouse fibroblast cell line temperature sensitive for expression of the transformed phenotype.
    Karrs TM; Quinlan DC
    J Cell Physiol; 1981 Jul; 108(1):67-76. PubMed ID: 7263768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential sensitivity of normal and H-ras oncogene-transformed rat kidney epithelial cells to okadaic acid-induced apoptosis.
    Davis MA; Chang SH; Trump BF
    Toxicol Appl Pharmacol; 1996 Nov; 141(1):93-101. PubMed ID: 8917680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
    Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
    J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth inhibition of oncogene-transformed rat fibroblasts by cocultured normal cells: relevance of metabolic cooperation mediated by gap junctions.
    Martin W; Zempel G; Hülser D; Willecke K
    Cancer Res; 1991 Oct; 51(19):5348-51. PubMed ID: 1913656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of a signal transduction pathway which controls disassembly of microfilament bundles and suppression of high-molecular-weight tropomyosin expression in oncogenic transformation of NRK cells.
    Masuda A; Takenaga K; Kondoh F; Fukami H; Utsumi K; Okayama H
    Oncogene; 1996 May; 12(10):2081-8. PubMed ID: 8668333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.